NATHAN KOTERA: Open Payments
NPI 1740511732 · WAHOO, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 12 payments from 7 companies in 2025. Trend: 2023 $327 · 2024 $368 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $72 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| PFIZER INC. | 2 | $30 |
| Lilly USA, LLC | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Seqirus USA Inc | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: LEQVIO, NURTEC ODT, ROTATEQ, VAXNEUVANCE, MOUNJARO, ENTRESTO, REXULTI, Fluad.
Industry payments across NE — which companies pay providers there.
